Survival expectation after thrombosis and overt-myelofibrosis in essential thrombocythemia and prefibrotic myelofibrosis: a multistate model approach

• Alessandra Carobbio,
• Alessandro Maria Vannucchi,
• Elisa Rumi,
• Valerio De Stefano,
• Alessandro Rambaldi,
• Giuseppe Carli,
• Maria Luigia Randi,
• Heinz Gisslinger,
• Francesco Passamonti,
• Juergen Thiele,
• Naseema Gangat,
• Ayalew Tefferi,
• Tiziano Barbui

Affiliations

Alessandra Carobbio

FROM Research Foundation, Papa Giovanni XXIII Hospital

Alessandro Maria Vannucchi

Center Research and Innovation of Myeloproliferative Neoplasms (CRIMM), Department of Experimental and Clinical Medicine, Azienda Ospedaliera Universitaria Careggi, University of Florence

Elisa Rumi

Department of Molecular Medicine, University of Pavia

Valerio De Stefano

Institute of Hematology, Catholic University

Alessandro Rambaldi

Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII

Giuseppe Carli

Division of Hematology, ‘‘S. Bortolo’’ Hospital

Maria Luigia Randi

Department of Medicine - DIMED, University of Padova

Heinz Gisslinger

Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna

Francesco Passamonti

Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan

Juergen Thiele

Institute of Pathology, University of Cologne

Naseema Gangat

Hematology Division, Mayo Clinic

Ayalew Tefferi

Hematology Division, Mayo Clinic

Tiziano Barbui

FROM Research Foundation, Papa Giovanni XXIII Hospital